Fulgent Genetics (FLGT) Total Current Liabilities (2016 - 2025)
Fulgent Genetics' Total Current Liabilities history spans 10 years, with the latest figure at $85.0 million for Q4 2025.
- For Q4 2025, Total Current Liabilities rose 16.55% year-over-year to $85.0 million; the TTM value through Dec 2025 reached $85.0 million, up 16.55%, while the annual FY2025 figure was $85.0 million, 16.55% up from the prior year.
- Total Current Liabilities for Q4 2025 was $85.0 million at Fulgent Genetics, up from $72.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $196.5 million in Q1 2021 and bottomed at $61.4 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $78.9 million (2023), against an average of $95.2 million.
- The largest annual shift saw Total Current Liabilities soared 3282.62% in 2021 before it crashed 49.17% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $105.3 million in 2021, then dropped by 16.34% to $88.1 million in 2022, then dropped by 17.13% to $73.0 million in 2023, then decreased by 0.16% to $72.9 million in 2024, then grew by 16.55% to $85.0 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Total Current Liabilities are $85.0 million (Q4 2025), $72.4 million (Q3 2025), and $71.3 million (Q2 2025).